1.
Dig Liver Dis
; 46(7): 659-60, 2014 Jul.
Artículo
en Inglés
| MEDLINE
| ID: mdl-24631030
Asunto(s)
Carcinoma Hepatocelular/diagnóstico por imagen , Neoplasias Hepáticas/diagnóstico por imagen , Regresión Neoplásica Espontánea , Neoplasias Primarias Múltiples/diagnóstico por imagen , Anciano , Aloe , Carcinoma Hepatocelular/patología , Humanos , Neoplasias Hepáticas/patología , Masculino , Neoplasias Primarias Múltiples/patología , Preparaciones de Plantas/uso terapéutico , Radiografía , Automedicación
2.
Recenti Prog Med
; 104(4): 168-76, 2013 Apr.
Artículo
en Italiano
| MEDLINE
| ID: mdl-23748641
RESUMEN
Surgery is an almost inevitable event in Crohn's disease but is not curative; post-operative recurrence follows a sequential and predictable course. Prevention of post-operative recurrence in Crohn's disease is therefore a relevant problem in the management of the disease. Several drugs have been evaluated to decrease the risk of recurrence: these include mesalazine, antibiotics, probiotics, budesonide, thiopurines and biologic agents. This review focuses on the randomised controlled trials and meta-analyses addressing different drugs and strategies for preventing post-operative recurrence in Crohn's disease.